A Food and Drug Administration expert found indications of safety problems with COVID-19 vaccines several months after they were authorized, according to newly released emails.
FDA leaders, informed of the findings, declined to make them public, according to records obtained by Sen. Ron Johnson (R-Wis.) and released on April 29.
Dr. Ana Szarfman, an FDA vaccine safety analytic expert at the time, met with Dr. Peter Marks, the FDA’s then-top vaccine official, and others at the agency on March 1, 2021, to discuss issues with the approach employed by the FDA to analyze the safety of vaccines following the emergency authorization of COVID-19 shots….